Metoprolol Medical Valley (Metoprolol Tartrate)

Metoprolol Tartrate selectively blocks β1‑adrenergic receptors in the heart. By inhibiting the action of adrenaline and noradrenaline at these sites, it reduces heart rate, myocardial contractility, and cardiac output, leading to lower blood pressure and decreased oxygen demand by the heart muscle.

The appropriate dose of Metoprolol Medical Valley is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any co‑existing health issues. Patients should follow the exact dosing instructions provided by their healthcare professional.

Safety data for Metoprolol Tartrate in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol is a cardio‑selective beta blocker, which differs from ACE inhibitors, ARBs, calcium‑channel blockers, and diuretics that target other pathways. Its advantage lies in reducing heart rate and myocardial oxygen demand, making it especially useful for patients with concomitant angina or post‑MI needs, whereas other classes may be preferred when bronchospasm risk is a concern.

Metoprolol Medical Valley should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat and direct sunlight to maintain potency throughout the shelf life.

The medication is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed.

Serious risks include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and rare allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience fainting, extreme fatigue, difficulty breathing, or swelling of the face or throat.

Metoprolol is contraindicated in patients with known hypersensitivity to metoprolol or any excipients, those with severe bradycardia, second‑ or third‑degree heart block without a pacemaker, cardiogenic shock, or uncontrolled heart failure. It should also be avoided in individuals with severe asthma or COPD where β‑blockade could precipitate bronchospasm.